Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Establishes Discovery Unit For Traditional Chinese Medicine

This article was originally published in PharmAsia News

Executive Summary

GSK transforms DPU in Shanghai into TCM discovery unit that will consist of a small number of select scientists with both Western drug discovery experience and TCM knowledge.

Advertisement

Related Content

GSK Says R&D Productivity Up, But Story Is About Culture, Not Numbers
Novo Nordisk Fights Back Dipping Sales In China By Expanding R&D, Manufacturing Capacity
GlaxoSmithKline R&D Under Scrutiny In Bid For Fresh Funding
AstraZeneca R&D VP Steve Yang On Building R&D Success In Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)
Putting The Pieces Together Again: GSK Creates End-To-End Business Units
Lilly Shifts Gears In China With New Shanghai-based R&D Center
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 1 of 2)

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC080708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel